BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023
Home » Topics » Financings, BioWorld

Financings, BioWorld
Financings, BioWorld RSS Feed RSS

Wuhan YZY raises $15 million in Hong Kong IPO to advance BsAbs

Sep. 22, 2023
By Tamra Sami
No Comments
Wuhan YZY Biopharma Co. Ltd. made its debut on the Hong Kong Stock Exchange, raising HK$121 million (US$15.48 million) in its IPO on Sept. 22, with shares (HKEX:02496) opening at the lower end of its range at HK$16 per share and ending the day at HK$16.60, a rise of 3.75%.
Read More

Financings for Sept. 22, 2023

Sep. 22, 2023
No Comments
Biopharmas raising money in public or private financings, including: Nantpharma, Oramed, Qihan, Scilex, Sorrento.
Read More

Chinabio 2023: Cansino, Gracell, Immuneonco’s C-suites offer IPO insights in China, US

Sep. 21, 2023
By Marian (YoonJee) Chu
No Comments
Raising capital has always been a challenge for small to medium biotech firms worldwide, but the economic whiplash and the wider downturn across international markets post-pandemic have pushed Chinese biotechs to make-it-or-break-it scenarios for crossing the IPO threshold, speakers at the Chinabio Partnering Forum 2023 said in Shanghai.
Read More

Financings for Sept. 21, 2023

Sep. 21, 2023
No Comments
Biopharmas raising money in public or private financings, including: Akari, Innocan, Lynk, Osteal, Seelos, Seraxis, Verimmune.
Read More

Financings for Sept. 20, 2023

Sep. 20, 2023
No Comments
Biopharmas raising money in public or private financings, including: Corsair, Hillevax, Mydecine, Rayzebio, Scinai, Tolremo, Transimmune.
Read More

ADAR on its radar: Airna launches to develop RNA therapeutics

Sep. 19, 2023
By Lee Landenberger
No Comments
Airna Corp. Inc. has launched through a $30 million financing to develop a pipeline of RNA editing therapeutics for treating rare diseases and prevalent diseases. It’s a wide spectrum of diseases made potentially more easily treatable because of the relatively recent revolution in RNA editing.
Read More
Layoff, shutdown illustration

Amid hard industry times, Histogen gives up as thinner Kinnate hangs on

Sep. 19, 2023
By Randy Osborne
No Comments
Having cast around for other routes, Histogen Inc. is throwing in the towel, its board having adopted a shutdown plan that includes the distribution of remaining cash to stockholders after a wind-down of operations. One of the company’s West Coast peers, Kinnate Biopharma Inc., had news, too. The firm disclosed the layoff of 70% of its workforce, including all employees at the Shanghai-based subsidiary Kinnjiu Biopharma Inc., leaving the outfit with 28 full timers.
Read More
Gold dollar sign inside gold cog

Pass the (molecular) glue: Magnet school teaches new way with $50M series A

Sep. 19, 2023
By Randy Osborne
No Comments
Magnet Biomedicine Inc. emerged from stealth mode and pulled down a $50 million series A round co-led by founding investor Newpath Partners alongside Arch Venture Partners. The firm is advancing molecular glue discovery by way of rational selection and design, looking past known protein-protein interactions and what Magnet calls “tangential” degradation approaches to analyze the broader protein landscape and ultimately pair targets with rationally chosen presenters in the tissue where the disease manifests.
Read More

Financings for Sept. 19, 2023

Sep. 19, 2023
No Comments
Biopharmas raising money in public or private financings, including: Atamyo, Bioloomics, Biora, Clearmind, Eloxx, Everimmune, Hyku, Recode.
Read More

Financings for Sept. 18, 2023

Sep. 18, 2023
No Comments
Biopharmas raising money in public or private financings, including: Aboleris, Acesis, Broken, Oxurion, Titan.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 207 208 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 22, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 22, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • New NLRP3 inflammasome inhibitors named in PTC Therapeutics patent

    BioWorld Science
    PTC Therapeutics Inc. has patented new NLRP3 inflammasome inhibitors reported to be useful...
  • Illustration of Alzheimer’s in the brain.

    Study identifies cause of death for Alzheimer’s neurons

    BioWorld
    By creating a new mouse model of Alzheimer’s disease that better recapitulated how the disease plays out in humans, investigators at KU Leuven have gained new...
BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing